Superseded public profile

U.S. label recordMetabolic

Superseded · version 1: Semaglutide

Related names recorded in this version: Wegovy

A GLP-1 receptor agonist represented by an exact current Wegovy label record and an FDA notice.

This is preserved historical wording.
It is no longer the current profile. Read the current profile and its correction notice.

What this version reported

The cited DailyMed label identifies Semaglutide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.

Organizations named in cited records:
  • U.S. National Library of Medicine

Sources for this version

  1. 1
    WEGOVY (semaglutide) injection and tablet · SPL version 19 · published 2026-06-30 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  2. 2
    FDA approves higher-dose semaglutide ↗

    U.S. Food and Drug Administration · Official source · Source checked July 22, 2026